| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 02/28/2008 | WO2008023796A1 Proteoglycan production accelerator |
| 02/28/2008 | WO2008023378A1 Conjugates of rgd peptides and porphyrin or (bacterio)chlorophyll photosynthesizers and their uses |
| 02/28/2008 | WO2007124284A3 Bombesin receptor anatogonists with anti-cancer activity |
| 02/28/2008 | US20080051434 Hemiasterlin derivatives and uses thereof in the treatment of cancer |
| 02/28/2008 | CA2661319A1 Conjugates of rgd peptides and porphyrin or (bacterio)chlorophyll photosynthesizers and their uses |
| 02/27/2008 | EP1891090A2 Macrocyclic ghrelin receptor antagonists and inverse agonists and methods of using the same |
| 02/27/2008 | EP1891089A2 Hcv protease inhibitors in combination with food |
| 02/27/2008 | EP1759207A4 P4has as modifiers of the igfr pathway and methods of use |
| 02/27/2008 | CN100371345C Perindopril |
| 02/27/2008 | CN100371019C Uro-genital condition treatment system |
| 02/26/2008 | US7335724 Peptides immunoreactive with autoantibodies from patients suffering from rheumatoid arthritis |
| 02/26/2008 | US7335722 For use in pharmaceuticals, food additivs |
| 02/26/2008 | US7335645 For prophylaxis or treatment of skin or mucosa, autoimmune diseases and inflammation |
| 02/26/2008 | US7335644 Angiotensin Converting Enzyme Inhibitors (ACEI); used to regulate blood pressure; enhanced bioavailability and fewer side effects |
| 02/26/2008 | US7335636 SPRR1A and axonal regeneration |
| 02/26/2008 | US7335632 Selectively inhibit memapsin 2 beta -secretase activity relative to memapsin 1 beta -secretase activity; Alzheimer's disease |
| 02/26/2008 | CA2138931C Method for determining platelet aggregation |
| 02/21/2008 | WO2008022006A2 Arylalkoxyl hepatitis c virus protease inhibitors |
| 02/21/2008 | WO2008021960A2 Triazolyl macrocyclic hepatitis c serine protease inhibitors |
| 02/21/2008 | WO2008020802A1 Cardioprotective compounds |
| 02/21/2008 | WO2008020778A1 Analgetically active peptide family |
| 02/21/2008 | WO2007149512A3 Peptide epoxyketones for pr0teas0me inhibition |
| 02/21/2008 | WO2007139914A3 Collagen mimics |
| 02/21/2008 | US20080045744 Synthesis of n-[n-(3,3-dimethylbutyl)-l-alpha-aspartyl]-l-phenylalanine 1-methyl ester using 3,3-dimethylbutyraldehyde precursors |
| 02/21/2008 | US20080045480 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 02/21/2008 | CA2661014A1 Cardioprotective compounds |
| 02/20/2008 | EP1888619A2 Compounds modifying apoptosis |
| 02/20/2008 | EP1888618A2 Analogs of glycyl-prolyl-glutamate |
| 02/20/2008 | EP1404704B9 Bridged bicyclic serine protease inhibitors |
| 02/20/2008 | EP1070726B1 Aspartyl dipeptide ester derivatives and sweeteners |
| 02/20/2008 | EP1064010B1 Peptide compositions and formulations and use of same |
| 02/20/2008 | CN100369891C HIF hydroxylase inhibitors |
| 02/19/2008 | US7332631 Fc receptor modulating compounds and compositions |
| 02/19/2008 | US7332567 Fret protease assays for clostridial toxins |
| 02/19/2008 | US7332473 derived from a PACAP or VIP peptide; can inhibit tautomerization in a solution; regressive neurodegenerative diseases, erectile dysfunction, and bronchial asthma; inhibited isomerization and high stability during the production and storage |
| 02/19/2008 | US7332149 Diagnosis, therapy of cancer, rheumatoid arthritis, for monitoring therapeutic angiogenesis treatment and destruction of new angiogenic vasculature, imaging tumors, atherosclerosis, restenosis, cardiac ischemia, and myocardial reperfusion injury |
| 02/19/2008 | CA2316310C Gamma-glutamyl and beta-aspartyl containing immunomodulator compounds and methods therewith |
| 02/14/2008 | WO2008019303A2 Pyridazinonyl macrocyclic hepatitis c serine protease inhibitors |
| 02/14/2008 | WO2008019289A2 Tetrazolyl macrocyclic hepatitis c serine protease inhibitors |
| 02/14/2008 | WO2008019266A2 Acyclic, pyridazinone-derived hepatitis c serine protease inhibitors |
| 02/14/2008 | WO2008001175A3 Dipeptide compounds containing d-histidine |
| 02/14/2008 | WO2007092582A3 Neutralization of bacterial spores |
| 02/14/2008 | US20080039449 [1,4]benzodiazepine derivatives, used for treating osteoarthritis, pancreatitis, glomerulonephritis, rheumatoid arthritis, inflammatory bowel disease, Crohn's disease, psoriasis, graft vs host disease, leukemia, septic shock, multiple sclerosis, and inflammatory bowel disease |
| 02/14/2008 | US20080039403 Exposing the cancer cell to a peptide has antiestrotrophic activity; inhibit estrogen receptor dependent cell proliferation; breast cancer |
| 02/14/2008 | US20080039375 Fused heterocycloalkyl ring substituted quinoxaline compounds, for example; interfere with the life cycle of the hepatitis C virus and are useful as antiviral agents |
| 02/14/2008 | US20080038783 Compositions and Methods Pertaining to Guanylation of PNA Oligomers |
| 02/14/2008 | US20080038208 Pharmaceutical/cosmetic compositions comprising the lysine-d-proline-valine tripeptide |
| 02/13/2008 | EP1885741A1 Lys-thr dipeptides and their use |
| 02/13/2008 | EP1885364A1 Halogenated quindoline dimers for the treatment of cancer |
| 02/13/2008 | EP1758923B1 Peptide substance restoring myocardium function |
| 02/13/2008 | EP1758922B1 Peptide substance restoring function of respiratory organs |
| 02/13/2008 | EP1379283B1 Identification of target-specific folding sites in peptides and proteins |
| 02/13/2008 | EP1082126B1 Novel peptides |
| 02/13/2008 | EP1062878B1 Mixed crystals comprising aspartame and aspartame derivative and process for producing the same |
| 02/13/2008 | EP0833652B1 Novel kappa receptor selective opioid peptides |
| 02/13/2008 | CN101124238A Antibody binding affinity ligands |
| 02/13/2008 | CN101123878A L-threonine derivatives of high therapeutic index |
| 02/13/2008 | CN101121745A Small molecular acidity peptide, extraction method thereof and pharmaceutical composition using the same as active ingredient |
| 02/13/2008 | CN100367949C Melanin extinguisher |
| 02/12/2008 | US7329644 Preparation and use of cyclic and branched peptides and their labelled derivatives as therapeutic agents, cholecystokinin agonists or antagonists, and diagnostic agents to identify and locate tumours |
| 02/12/2008 | US7329507 Linking oligopeptide to a stabilizing group, linking the oligopeptide to a therapeutic agent, testing if the conjugate is cleavable by Thimet oligopeptidase |
| 02/12/2008 | CA2315532C Cyclopeptide derivatives with integrin inhibitor properties |
| 02/12/2008 | CA2274132C Macrocyclic metal complex carboxylic acids, use and method for the production thereof |
| 02/12/2008 | CA2234716C Peptides for treatment of inflammation and shock |
| 02/07/2008 | WO2008016893A1 Smac peptidomimetics useful as iap inhibitors |
| 02/07/2008 | WO2008014613A1 Multifunctional bioactive compounds |
| 02/07/2008 | WO2008014603A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 02/07/2008 | US20080032936 Quinoxalinyl tripeptide hepatitis C virus inhibitors |
| 02/07/2008 | US20080032917 Flavivirus protease substrates and inhibitors |
| 02/07/2008 | DE102006035899A1 New polysaccharide-peptide-conjugate, where the peptide portion contains a sequence having a signal group that is splittable by thrombin at its carbon-terminal end, useful in a procedure for determining the thrombin generation in a sample |
| 02/07/2008 | CA2659875A1 Multifunctional bioactive compounds |
| 02/07/2008 | CA2658525A1 Smac peptidomimetics useful as iap inhibitors |
| 02/06/2008 | CN101117334A Novel method for synthesizing L-carnosine |
| 02/05/2008 | US7326795 efficient resolution, purification and isolation of intermediate compounds, and a one step neutralization/coupling procedure |
| 02/05/2008 | US7326768 Goodpasture antigen-binding protein isoforms and protein misfolded-mediated disorders |
| 02/05/2008 | US7326707 Bicyclic melanocortin-specific compounds |
| 02/05/2008 | US7326566 Compositions and methods for screening antimicrobials |
| 02/05/2008 | CA2315703C Tripeptidyl peptidase inhibitors |
| 02/05/2008 | CA2310761C Sweetener compositions containing aspartame and aspartame derivative |
| 02/05/2008 | CA2310760C Mixed crystals comprising aspartame and aspartame derivative and process for producing the same |
| 02/05/2008 | CA2136339C Derivatives of dolastatin |
| 01/31/2008 | WO2008014252A2 Iap inhibitors |
| 01/31/2008 | WO2008014229A2 Dimeric iap inhibitors |
| 01/31/2008 | WO2008012086A2 Protein-binding methotrexate derivatives, and medicaments containing the same |
| 01/31/2008 | WO2007136295A3 Peptide substance revealing a stress protective effect, pharmaceutical composition on its base and the method of its application |
| 01/31/2008 | WO2006092722A8 Peptidomimetic compounds and preparation of biologically active derivatives |
| 01/31/2008 | US20080027212 Methods and compositions for improved uptake of biological molecules |
| 01/31/2008 | US20080027211 Enantiopure Heterocyclic Compound Useful for the Preparation of Peptides Which Can Be Potentially Used as Medicaments |
| 01/31/2008 | US20080027060 Dipeptide nitriles |
| 01/31/2008 | US20080027038 N-Acylated lipophilic amino acid derivatives |
| 01/31/2008 | DE102006035083A1 Proteinbindende Methotrexat-Derivate und diese enthaltende Arzneimittel Protein-binding methotrexate derivatives and pharmaceutical compositions containing them |
| 01/31/2008 | CA2657706A1 Dimeric iap antagonists |
| 01/31/2008 | CA2595158A1 Polysaccharide-peptide conjugates for use as thrombin substrates |
| 01/30/2008 | EP1881962A2 Thiosuccinic acid derivatives and the use thereof |
| 01/30/2008 | CN100364606C Peptide compositions and formulations and use of same |
| 01/29/2008 | US7323489 As prodrug of enalaprilat, which is a medicine useful for preventing or treating circulatory diseases such as hypertension, cardiac diseases, nephritis, and apoplexy, patches; 1-[N-[(1S)-1-Carboxy-3-phenylpropyl]-L-alanyl]-L-proline 2-hydroxyethyl ester |
| 01/29/2008 | US7323457 Containing a perhydro-4-benzodiazepinylphenyl group 1-substituted with a methylaminoacetyl-, 4-piperidinylcarbonyl- or 2-pyrrolidinylcarbonyl- group: 4-(Piperidin-4-yl)carbonyl-1-{[2-(2-benzofuranoyl)amino]-4-[1-aminocarbonyl-2-(2-naphthyl)ethylamino]carbonylaminophenyl}homopiperazine; osteoporosis |
| 01/29/2008 | US7323448 Antibacterial agents |
| 01/29/2008 | CA2383298C New amino acids, their preparation process and pharmaceutical compositions that contain these amino acids |
| 01/29/2008 | CA2271735C Magnetic resonance blood pool agents |